Skip to main content

In the Literature

In the Literature, Oncology

Pembrolizumab Shows Long-Term Benefits in Metastatic Colorectal Cancer and MSI-H or dMMR

In the Literature, Gastroenterology, Oncology

Sitagliptin, DPP-4 Inhibitor, Reduces the Incidence of Acute GVHD After Stem-Cell Transplant

In the Literature, Oncology

Luspatercept Effective in Patients with Lower-Risk Myelodysplastic Syndromes

In the Literature, Oncology

Split-Fill Program for Oncology Oral Medications Is Cost-Saving

In the Literature, Oncology

Real-World Evidence Supports Patient Navigation in Cancer

In the Literature, Oncology

Luspatercept Effective in Patients with Lower-Risk Myelodysplastic Syndromes

In the Literature, Oncology

Long-Term Outcomes Affect Cost-Effectiveness of CAR T-Cell Therapy for DLBCL

In the Literature, Oncology

Alpelisib Prolongs Progression-Free Survival in Advanced Breast Cancer with PIK3CA Mutation

In the Literature, Oncology

New Triple-Drug Regimen for Newly Diagnosed Patients with Multiple Myeloma

In the Literature, Oncology

Ibrutinib Superior to Standard Chemoimmunotherapy in Older Patients with CLL

Page 1 of 2
Results 1 - 10 of 13